{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:30:12Z","timestamp":1732041012273},"reference-count":38,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2021.1492","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:19:58Z","timestamp":1638872398000},"source":"Crossref","is-referenced-by-count":3,"title":["The impact of single\u2011nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct\u2011acting antiviral drugs for hepatitis C infection"],"prefix":"10.3892","volume":"16","author":[{"given":"Kosuke","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852\u20118501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisamitsu","family":"Miyaaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852\u20118501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852\u20118501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852\u20118501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Haraguchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852\u20118501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Miuma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852\u20118501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852\u20118501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"key20220302121524_b1-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1101\/gr.088013.108","article-title":"SNP detection for massively parallel whole-genome resequencing","volume":"19","author":"Li","year":"2009","journal-title":"Genome Res"},{"key":"key20220302121524_b2-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"E137","DOI":"10.1111\/hepr.12258","article-title":"Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection","volume":"44","author":"Sato","year":"2014","journal-title":"Hepatol Res"},{"key":"key20220302121524_b3-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00535-014-1018-z","article-title":"Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C","volume":"50","author":"Yasui","year":"2015","journal-title":"J Gastroenterol"},{"key":"key20220302121524_b4-BR-16-2-01492","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2019.4.09","article-title":"Association between PNPLA3[G]\/I148M variant, steatosis and fibrosis stage in hepatitis C virus-genetic matters","volume":"70","author":"Crisan","year":"2019","journal-title":"J Physiol Pharmacol"},{"key":"key20220302121524_b5-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1053\/j.gastro.2017.01.041","article-title":"Genome-wide association study identifies TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus infection","volume":"152","author":"Matsuura","year":"2017","journal-title":"Gastroenterology"},{"issue":"15058","key":"key20220302121524_b6-BR-16-2-01492","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33448-1","article-title":"Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals","volume":"8","author":"Huang","year":"2018","journal-title":"Sci Rep"},{"key":"key20220302121524_b7-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00535-018-1526-3","article-title":"TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy","volume":"54","author":"Iio","year":"2019","journal-title":"J Gastroenterol"},{"key":"key20220302121524_b8-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jhep.2010.03.022","article-title":"Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients","volume":"53","author":"Abe","year":"2010","journal-title":"J Hepatol"},{"key":"key20220302121524_b9-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jhep.2011.01.050","article-title":"IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C","volume":"55","author":"Bochud","year":"2011","journal-title":"J Hepatol"},{"key":"key20220302121524_b10-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jhep.2010.07.037","article-title":"Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors","volume":"54","author":"Kurosaki","year":"2011","journal-title":"J Hepatol"},{"key":"key20220302121524_b11-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s00535-012-0550-y","article-title":"IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients","volume":"47","author":"Ohnishi","year":"2012","journal-title":"J Gastroenterol"},{"key":"key20220302121524_b12-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s00535-013-0858-2","article-title":"Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C","volume":"49","author":"Asahina","year":"2014","journal-title":"J Gastroenterol"},{"issue":"e91822","key":"key20220302121524_b13-BR-16-2-01492","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091822","article-title":"Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: A meta-analysis","volume":"9","author":"Sato","year":"2014","journal-title":"PLoS One"},{"issue":"e0137351","key":"key20220302121524_b14-BR-16-2-01492","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137351","article-title":"Genetic polymorphisms of IL28B and PNPLA3 are predictive for HCV related rapid fibrosis progression and identify patients who require urgent antiviral treatment with new regimens","volume":"10","author":"Tamaki","year":"2015","journal-title":"PLoS One"},{"key":"key20220302121524_b15-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1478-3231.2008.01691.x","article-title":"Utilization rates, complications and costs of percutaneous liver biopsy: A population-based study including 4275 biopsies","volume":"28","author":"Myers","year":"2008","journal-title":"Liver Int"},{"key":"key20220302121524_b16-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): A novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"key":"key20220302121524_b17-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J Gastroenterol"},{"key":"key20220302121524_b18-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4292\/wjgpt.v7.i1.33","article-title":"Hepatitis C virus: A time for decisions. Who should be treated and when?","volume":"7","author":"Attar","year":"2016","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"key20220302121524_b19-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/hep.28473","article-title":"Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)","volume":"63","author":"Leroy","year":"2016","journal-title":"Hepatology"},{"key":"key20220302121524_b20-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jmv.24950","article-title":"Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b","volume":"90","author":"Ogasawara","year":"2018","journal-title":"J Med Virol"},{"key":"key20220302121524_b21-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"Ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"key20220302121524_b22-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1055\/s-0033-1335205","article-title":"EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology","volume":"34","author":"Bamber","year":"2013","journal-title":"Ultraschall Med"},{"key":"key20220302121524_b23-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/hep.25993","article-title":"Determination of reliability criteria for liver stiffness evaluation by transient elastography","volume":"57","author":"Boursier","year":"2013","journal-title":"Hepatology"},{"key":"key20220302121524_b24-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00535-015-1127-3","article-title":"Appropriate use of virtual touch quantification and FibroScan M and XL probes according to the skin capsular distance","volume":"51","author":"Kumagai","year":"2016","journal-title":"J Gastroenterol"},{"key":"key20220302121524_b25-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mrfmmm.2005.01.008","article-title":"Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP genotyping assays and the SNPlex genotyping system","volume":"573","author":"De la Vega","year":"2005","journal-title":"Mutat Res"},{"key":"key20220302121524_b26-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"key20220302121524_b27-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/hepr.12840","article-title":"Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis\/fibrosis progression","volume":"47","author":"Seko","year":"2017","journal-title":"Hepatol Res"},{"key":"key20220302121524_b28-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"key20220302121524_b29-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.23744","article-title":"Outcome of sustained virological responders with histologically advanced chronic hepatitis C","volume":"52","author":"Morgan","year":"2010","journal-title":"Hepatology"},{"key":"key20220302121524_b30-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"key20220302121524_b31-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000470910","article-title":"Outcome of all-oral direct-acting antiviral regimens on the rate of development of hepatocellular carcinoma in patients with hepatitis C virus genotype 1-related chronic liver disease","volume":"93","author":"Ogata","year":"2017","journal-title":"Oncology"},{"key":"key20220302121524_b32-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/cncr.20537","article-title":"Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy","volume":"101","author":"Makiyama","year":"2004","journal-title":"Cancer"},{"key":"key20220302121524_b33-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/hep.26442","article-title":"\u03b1-Fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C","volume":"58","author":"Asahina","year":"2013","journal-title":"Hepatology"},{"key":"key20220302121524_b34-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.28535","article-title":"Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection","volume":"64","author":"El-Serag","year":"2016","journal-title":"Hepatology"},{"key":"key20220302121524_b35-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.jhep.2018.07.024","article-title":"Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C","volume":"69","author":"Ioannou","year":"2018","journal-title":"J Hepatol"},{"issue":"e0194163","key":"key20220302121524_b36-BR-16-2-01492","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194163","article-title":"Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication","volume":"13","author":"Motoyama","year":"2018","journal-title":"PLoS One"},{"key":"key20220302121524_b37-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.3748\/wjg.v13.i39.5180","article-title":"Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C","volume":"13","author":"Tanaka","year":"2007","journal-title":"World J Gastroenterol"},{"key":"key20220302121524_b38-BR-16-2-01492","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/hep.24624","article-title":"Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients","volume":"55","author":"Myers","year":"2012","journal-title":"Hepatology"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T10:19:07Z","timestamp":1646216347000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2021.1492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,7]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2021.1492","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]},"article-number":"9"}}